Cargando…
The role of exome sequencing in childhood interstitial or diffuse lung disease
BACKGROUND: Children’s interstitial and diffuse lung disease (chILD) is a complex heterogeneous group of lung disorders. Gene panel approaches have a reported diagnostic yield of ~ 12%. No data currently exist using trio exome sequencing as the standard diagnostic modality. We assessed the diagnosti...
Autores principales: | Temple, Suzanna E. L., Ho, Gladys, Bennetts, Bruce, Boggs, Kirsten, Vidic, Nada, Mowat, David, Christodoulou, John, Schultz, André, Gayagay, Thet, Roscioli, Tony, Zhu, Ying, Lunke, Sebastian, Armstrong, David, Harrison, Joanne, Kapur, Nitin, McDonald, Tim, Selvadurai, Hiran, Tai, Andrew, Stark, Zornitza, Jaffe, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463757/ https://www.ncbi.nlm.nih.gov/pubmed/36085161 http://dx.doi.org/10.1186/s13023-022-02508-1 |
Ejemplares similares
-
Genomic testing for children with interstitial and diffuse lung disease (chILD): parent satisfaction, understanding and health-related quality of life
por: Kelada, Lauren, et al.
Publicado: (2022) -
Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: a decade’s experience
por: Saddi, Vishal, et al.
Publicado: (2017) -
Elusive variants in autosomal recessive disease: how can we improve timely diagnosis?
por: Horton, Ari E., et al.
Publicado: (2023) -
Intronic variants in inborn errors of metabolism: Beyond the exome
por: Hertzog, Ashley, et al.
Publicado: (2022) -
Asthma and Susceptibility to COVID-19 in Australian Children During Alpha, Delta and Omicron Waves of the COVID-19 Pandemic
por: Chan, Mei, et al.
Publicado: (2023)